NRx Pharmaceuticals' stock jumps following new analysis of its potential Covid-19 drug
November 29, 2021 at 13:57 PM EST
A new analysis compared the Radnor firm's potential treatment to other therapies now being used to treat Covid-19.
 |
||||||||||||
|
||||||||||||
| About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map | ||||||||||||
Photos copyright by Jay Graham Photographer
